{
    "applicationNumber": "BR 11 2022 016868-3",
    "filingDate": "01/03/2021",
    "grantDate": null,
    "title": "COMPOSI\u00c7\u00d5ES FARMAC\u00caUTICAS QUE COMPREENDEM 2-[(4S)-8-FLUORO-2-[4-(3-METOXIFENIL)PIPERAZIN-L-IL]-3-[2-METOXI-5-(TRIFLUOROMETIL)FENIL]-4H-QUINAZOLIN-4-IL]ACETATO E \u00cdONS DE S\u00d3DIO",
    "nationalPhaseDate": [
        "24/08/2022"
    ],
    "internationalApplication": {
        "pctNumber": "PCT EP2021/055057",
        "pctDate": "01/03/2021",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "EP",
            "priorityNumber": "20159711.9",
            "priorityDate": "27/02/2020"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2696"
        },
        {
            "code": "1.5",
            "description": "Exig\u00eancias Diversas",
            "bulletinNumber ": "2709"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2721"
        }
    ],
    "inventors": [
        "HELMUT BUSCHMANN",
        "THOMAS GOLDNER",
        "JESSICA REDMER",
        "JORDI CARLES CERON BERTRAN",
        "ANDREA HAWE",
        "MATTHIAS LUCKE",
        "DOROTHEA HOHMANN",
        "MONICA ROSA"
    ],
    "holders": [
        323849
    ],
    "ipcCodes": [
        "A61P 31/22",
        "A61K 9/10",
        "A61K 9/08",
        "A61K 31/00",
        "A61K 9/19"
    ]
}